4D
4D Pharma
Leeds UKFounded 201480 employees
Private CapbiotechAcquiredGI
Platform: MRx Microbiome
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
0
FDA Approved
2
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sotoglumide | 4D-7183 | Phase 2/3 | 2 | MALT1 | ObesityRSV | ||
| 4D-8297 | 4D-8297 | Phase 1/2 | 2 | GPRC5D | Heart Failure | ||
| 4D-3071 | 4D-3071 | Approved | 1 | BCMA | ALSRB | ||
| 4D-4097 | 4D-4097 | Approved | 1 | Nectin-4 | AngelmanMyelofibrosis |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)